Tokyo, Japan

Takuya Okazaki

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dai Nippon Printing Co., Ltd., National Center for Child Health and Development. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Okazaki. Retrieved from https://idiyas.com/inventor/takuya-okazaki-qpetrax4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takuya Okazaki: Innovator in Gut Organoid Technology

Introduction

Takuya Okazaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of gut organoids. His innovative work has the potential to advance drug testing and disease modeling.

Latest Patents

Takuya Okazaki holds a patent for a gut organoid and the method for producing the same. The gut organoid features a tissue structure that encloses a cavity. The method involves providing a test drug to the gut organoid in the presence of a buffer solution, allowing the liquid containing the test drug to enter the cavity. Subsequently, the liquid in the cavity is collected and analyzed. The production method includes plating cells on a cell culture substrate with a cell-adhesive region and a non-cell-adhesive region, followed by culturing the cells to induce differentiation.

Career Highlights

Throughout his career, Takuya Okazaki has worked with notable organizations, including Dai Nippon Printing Co., Ltd. and the National Center for Child Health and Development. His experience in these institutions has enriched his expertise in research and development.

Collaborations

Takuya has collaborated with esteemed colleagues such as Akihiro Umezawa and Hidenori Akutsu. These partnerships have fostered a collaborative environment that enhances innovation in their respective fields.

Conclusion

Takuya Okazaki's contributions to gut organoid technology exemplify the intersection of innovation and biomedical research. His work not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…